Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma

Condition:   Primary Central Nervous System Lymphoma Intervention:   Drug: rituximab in combination with methotrexate, cytarabine and dexamethasone Sponsor:   Mingzhi Zhang Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials